Including obesity drugs among the WHO’s essential medicines could have great significance for that population. Experts say that adding HIV drugs to the list in 2002 helped to make them much more ...

Looking for successors to the blockbuster GLP-1 obesity drugs, companies like Novo Nordisk and Eli Lilly are testing amylin ...

Wegovy, Zepbound and similar medications all lead to metabolic improvements, but scientists are starting to unpick the ...

Some Medicare members could get help paying for the popular new weight-loss drug Wegovy ... from paying for obesity medicines, while some commercial plans have resisted adding reimbursement ...

Weight loss drugs like Ozempic are all over the news. Here's what I'm reading to keep up as a health reporter.

The drug companies behind blockbuster weight loss and diabetes treatments have signaled that supply problems could soon be ...

The widespread use and enormous expense of blockbuster drugs like Wegovy are forcing state governments to make painful ...

But does this new version of the drug come with its own costs? Zepbound is the latest drug to join the growing list of anti-obesity medications ... denied access to the essential treatment and ...

Novo Nordisk remained laser-focused on improving its diabetes drug. As The New York Times has noted, weight loss was lower on its list of ... sales of obesity management medications hit $6 billion ...

The new classes of obesity medications—GLP-1 and GLP ... For insurers who do cover weight loss products, in the short term the drugs may be adding costs to the healthcare system without ...

New weight loss medications, including Wegovy and Zepbound, may be able to help patients lose enough weight to undergo operations. However, the amount of weight loss they provide may be insufficient ...

Nearly 10,000 Michigan residents using anti-obesity ... access to the medicines and is actively working with legislators and pharmaceutical companies "to make these essential drugs more affordable ...